Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v3.19.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Paid in capital
Accumulated Other Comprehensive Income
Retained earnings
Beginning Balance at Dec. 31, 2016 $ 40,550,196 $ 76,195 $ 33,881,863 $ 718,463 $ 5,873,675
Beginning Balance, shares at Dec. 31, 2016   7,619,469      
Net income (loss) (146,290)       (146,290)
Unrealized gain (loss) on available-for-sale securities 78,140     78,140  
Dividends (1,981,062)       (1,981,062)
Ending Balance at Dec. 31, 2017 $ 38,500,984 $ 76,195 33,881,863 796,603 3,746,323
Ending Balance, shares at Dec. 31, 2017 7,619,469 7,619,469      
Net income (loss) $ 619,448       619,448
Restricted stock grants issued   $ 731 (731)    
Restricted stock grants issued, Shares   73,155      
Compensation expense related to stock-based awards 80,771   80,771    
Dividends (1,995,327)       (1,995,327)
Ending Balance at Dec. 31, 2018 $ 37,205,876 $ 76,926 $ 33,961,903   3,167,047
Ending Balance, shares at Dec. 31, 2018 7,692,624 7,692,624      
Adjustment from financial instruments update ASU 2016-01 (Note 2)       $ (796,603) $ 796,603